Rejected at 1:26 a.m. Nov, 01, 2023 ] by dollajas
Author: heptachlor
Related Note: 1488418305850
Rationale for change

cloze

Text Text
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo
Empty field
Bootcamp
OME
Additional Resources
One by one
Empty field
#AK_Step3_v12::#UWorld::10150 #AK_Other::#AK_Original_Decks::Step_1::Zanki_Step_Decks::Zanki_Musculoskeletal::Musculoskeletal_Pathology #AK_Step1_v12::#B&B::15_MSK::03_Pathology::07_Muscle_Disorders::Extra #AK_Step2_v12::#AMBOSS::Ro0lbS #AK_Step1_v12::#Physeo::11_Pathology::04_Musculoskeletal_Pathology::06_Skeletal_Muscle_Disorders #AK_Step1_v12::#NBME::16 #AK_Step1_v12::#SketchyPath::11_Immunology::01_Autoimmune_&_Amyloidosis::03_Polymyositis_&_Dermatomyositis #AK_Step1_v12::#Pathoma::18_MSK::04_Skeletal_Muscle #AK_Other::AnKing_Image::Michael #AK_Step2_v12::#SketchyIM::07_Rheumatology::01_Approach_To_Clinical_Conditions::02_Autoantibodies_In_Rheumatic_Diseases #AK_Step2_v12::#AMBOSS::IM0YJg #AK_Step1_v12::#Pathoma::18_MSK::04_Skeletal_Muscle::skeletal #AK_Step2_v12::#SketchyIM::07_Rheumatology::07_Systemic_Diseases::03_Scleroderma #AK_Step2_v12::#SketchyIM::07_Rheumatology::06_Myofascial_Disorders::02_Polymyalgia_Rheumatica #AK_Step1_v12::#Bootcamp::Musculoskeletal::03_Rheumatologic_Disease::07_Polymyositis_and_Dermatomyositis #AK_Step1_v12::^Systems::Musculoskeletal::Pathology #AK_Other::AnKing_Image::!Subjects::Orthopedics_&_Rheumatology::Dermatomyositis_vs_polymyositis #AK_Step2_v12::#AMBOSS::ow00PR #AK_Step1_v12::#FirstAid::11_Musculoskeletal_Skin_and_Connective_Tissue::02_Pathology::29_Polymyositis/dermatomyositis::02_Dermatomyositis #AK_Step1_v12::#DirtyMedicine::04_Pathology::05_Autoantibodies_Rapid_Review #AK_Step1_v12::#FirstAid::02_Immunology::03_Immune_Responses::15_Autoantibodies #AK_Step2_v12::#SketchyIM::07_Rheumatology::05_Muscle_Disorders::01_Immune_Mediated_Myopathies:_Dermatomyositis_&_Polymyositis #AK_Step1_v12::#AMBOSS::ZfaZkP #AK_Other::AnKing_Image::Mujeeb::Dermatomyositis_vs_polymyositis #AK_Step1_v12::#Bootcamp::Biochemistry::01_Cell_Biology::03_Signal_Recognition #AK_Step1_v12::#FirstAid::11_Musculoskeletal_Skin_and_Connective_Tissue::02_Pathology::29_Polymyositis/dermatomyositis::01_Polymyositis #AK_Step2_v12::#SketchyNeurology::10_Neuromuscular_Disorders::02_Myopathy::01_Immune-Mediated_Myopathy:_Dermatomyositis/Polymyositis #AK_Step1_v12::#OME::02_The_Cell::01_Cell_Physio::13_Myopathies #AK_Step1_v12::#FirstAid::11_Musculoskeletal_Skin_and_Connective_Tissue::02_Pathology::29_Polymyositis/dermatomyositis #AK_Step1_v12::#OME::PreClinical::02_The_Cell::01_Cell_Physio::13_Myopathies #AK_Other::Only_Step_1&2_Overlap #AK_Step2_v12::#AMBOSS::Zu0Zp3 #PANCE::EOR::IM #AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Step2_v12::#SketchyNeurology::10_Neuromuscular_Disorders::02_Myopathies::02_Immune-Mediated_Myopathy:_Dermatomyositis_&_Polymyositis #AK_Step2_v12::#B&B::09_MSK::01_General::08_Muscle_Disorders::Extra